Current results with myeloablative therapy with hematopoietic support in advanced neuroblastoma

Cancer Research Therapy and Control

Volumn 9, Issue 1-2, 1999, Pages 89-94

  Matthay, Katherine K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allogeneic; Autologous; Bone marrow transplantation; Chemotherapy; Neuroblastoma; Purging

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; MYELOABLATIVE AGENT; RETINOIC ACID; TENIPOSIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; NEUROBLASTOMA; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR CELL; WHOLE BODY RADIATION;

EID: 0032873051     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. August CS, Serota IT, Koch PA, Burkey E, Schlesinger H, Elkins WL, Evans AE, D'Angio GJ. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 1984; 2:609-616.
2. Campbell, LA, Seeger RC, Harris RE, Villablanca JG, Matthay KK. Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma. J Clin Onco/1993-, 11:623-629.
3. Cheung NKV and Heller G. Chemotherapy dose intensity correlates strongly with response, median survival and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 1991, 9:1050-1058.
4. Dini G, Lanino E, Garaventa A et al: Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: Report of 34 cases. J Clin Oncol 1991; 9:962-969.
5. Graham Pole J, Casper J, Elfenbein G et al: High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pédiatrie Oncology Group study. J Clin Oncol 1991; 9:152-158.
6. Haase G, O'Leary MC, Ramsay NK, Romansky SO, Stram D, Seeger RC, Hammond GD: Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg 1991; 26:1119-1124.
7. Kalra R, Zoger S, Kosovich MS, Matthay KK: Military spread of neuroblastoma: Radiological Case of the Month. Arch Fed Adolesc Med, 1995; 149:194-195.
8. Kushner BH, O'Reilly RJ, Mandell LR et al: Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 1991 ; 9:274-279.
9. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992; 52:4701-4705.
10. 131I-metaiodobenzyl-guanidine (MIBG) therapy for patients with refractory neuroblastoma. J Nucl Biol Med 1991; 35:244-247.
11. Matthay KK, Atkinson JB, Reynolds CP, Selch M, Seeger RC. Patterns of relapse alter autologous bone marrow transplantation for neuroblastoma. J Clin Oncol 1993; 11 :2226-2233.
12. Matthay KK. Neuroblastoma. In: Neoplastic Diseases in Childhood. (C. Pochedly, ed.) Harwood Academic Publishers, 1994, pp 735-778.
13. Matthay KK, Seeger RC, Reynolds, CP, Stram D, O'Leary M, Harris RE, Selch M, Atkinson J, Haase G, Hammond GD, Ramsay NK. Allogeneic vs autologous purged bone marrow transplantation for neuroblastoma. J Clin Oncol 1994; 12:2382-2389.
14. Matthay K, Reynolds CP, Atkinson 1, Selch M, Stram D, Harris R, Ramsay N, Moss T, Feig S, Villablanca J, Seeger R: Risk groups among 131 children with stage IV neuroblastoma undergoing autologous BMT: a Childrens Cancer Group study. Med Pediatr Oncol, in press, 1995 (abstr)
15. Moss TJ, Reynolds CP, Sather HN et al: Prognostic value of immunocytologic detection of bone marrow métastases in neuroblastoma. N Engl J Med 324:219-226, 1991
16. Moss TJ, Cairo M, Santana VM, Weinthal J, Hurvitz C, Bostrom B: Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood 1994; 83:3085-3089.
17. Ohnuma N, Takahashi H, Kaneko M et at: Treatment combined with bone marrow transplantation for advanced neuro-blastoma: An analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan. Med Pediatr Oncol 1995; 24:181-187.
18. Philip T, Zucker JM, Bernard JL, et al: Improved survival at 2 arid 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than I year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 1991; 9:10371044.
19. Reynolds CP, Seeger RC, Vo DD, Black AT, Wells J, Ugetstad J. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 1986; 46:5882-5886.
20. Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Grouse VL, Wilbur JR, Shurin SB, Seeger RC Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol A 1991; 366:203-211.
21. Rill DR, Santana VM, Roberts M et al: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380383,1994
22. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of the MYCN oncogene with rapid progression of neuroblastomas.N Engl J Med 1985; 313: 1111-1116.
23. Seeger RC, Villablanca JG, Matthay KK, Harris R, Moss TJ, Feig SA, Selch M, Ramsay N, Reynolds CP. Intensive chemoradiotherapy and autologous bone marrow transplanta-tion for poor prognosis neuroblastoma. Prog Clin Biol Res 1991; 366:527-534.
24. Shimada H, Steam DO, Chatten 1, Joshi VV, Hachitanda Y, Brodeur CM, Lukens JN, Matthay KK, Seeger RC. Combined histopathologic and MYCN gene analysis identifies subsets of neuroblastomas. JNCI, 1995; 87:1472-76.
25. Shuster JL, Cantor AB, McWilliams N et al. The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J din Oncol 1991; 9:1045-1049.
26. Steam DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, Seeger RC. Consolidation chemoradiotherapy and autologous bone marrow transplantation vs. continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies. J Clin Oncol, in press, 1996.
27. Suzuki T, Bogenmann E, Shimada H, Steam D, Seeger RC. Aggressive neuroblastomas lack high affinity nerve growth factor receptors. J Natl Cancer Inst 1993, 85:377-384.
28. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NKC, Reynolds CP. Phase 1 trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol, 1995; 13 :894-901.
29. Villablanca JG, Matthay KK, Ramsay NK, et al. Carboplatin, etoposide, melphalan, and local irradiation (CEL-LI) with autologous bone marrow transplantation (ABMT) for high risk neuroblastoma. Proc Amer Soc Clin Oncol 1995; 14: 440(abstract)